Yukina Morimoto

641 citations
33 papers · 483 indexed · h-index 14
Topics
Glioma Diagnosis and Treatment (17 papers)Neurofibromatosis and Schwannoma Cases (13 papers)Meningioma and schwannoma management (9 papers)
Partner nations
JapanEgyptUnited Kingdom

In The Last Decade

Yukina Morimoto

32 papers receiving 478 citations

Peers

Yukina Morimoto
Comparison fields: 5 of 58
  • Genetics 196
  • Oncology 126
  • Molecular Biology 125
  • Immunology 114
  • Epidemiology 108
Replace Mareina Kudo with:
Mareina Kudo Japan
Lingyang Hua China
Yugo Kishida Japan
Suvendu Purkait India
Karine Durand France
Bruce Frankel United States
Yuuta Kamoshima Japan
Taohui Ouyang China
Prit Benny Malgulwar India
Zachary R. Barnard United States
Yukina Morimoto relative to Mareina Kudo Japan Mareina Kudo's profile →
Citations per field
00.5×4.4×
Mareina Kudo · 1×
Citations per year

Countries citing papers authored by Yukina Morimoto

Since Specialization
Citations

This map shows the geographic impact of Yukina Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukina Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukina Morimoto more than expected).

Fields of papers citing papers by Yukina Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukina Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukina Morimoto. The network helps show where Yukina Morimoto may publish in the future.

Co-authorship network of co-authors of Yukina Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yukina Morimoto. A scholar is included among the top collaborators of Yukina Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukina Morimoto. Yukina Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 4
4 1
5 4
6 11
7 5
8 4
9 21
10 17
11 1
12 17
13 3
14 37
15 58
16 15
17 14
18 8
19 38
20 13

About Yukina Morimoto

Yukina Morimoto is a scholar working on Genetics, Neurology and Rheumatology, having authored 33 papers that have together received 483 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Neurofibromatosis and Schwannoma Cases (13 papers) and Meningioma and schwannoma management (9 papers). The work is most often cited by research in Genetics (196 citations), Neurology (104 citations) and Immunology (114 citations). Yukina Morimoto has collaborated with scholars based in Japan, Egypt and United Kingdom. Frequent co-authors include Kazunari Yoshida, Ryota Tamura, Masahiro Toda, Kenzo Kosugi, Kentaro Ohara, Hikaru Sasaki, Mizuto Sato, H. Tamura, Toshihide Tanaka and Yuichi Murayama. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026